Elbert Huang to Child
This is a "connection" page, showing publications Elbert Huang has written about Child.
Connection Strength
0.679
-
Diffusion and Disparities: Rural Uptake of Continuous Glucose Monitors. Diabetes Care. 2024 Mar 01; 47(3):344-345.
Score: 0.109
-
14. Children and Adolescents: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S208-S231.
Score: 0.094
-
Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured Children. Pediatrics. 2020 02; 145(2).
Score: 0.082
-
Use of Low-Value Pediatric Services Among the Commercially Insured. Pediatrics. 2016 12; 138(6).
Score: 0.066
-
Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010 Sep; 12(9):679-84.
Score: 0.043
-
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2010 Jun; 33(6):1269-74.
Score: 0.041
-
JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008 Aug; 10(4):310-21.
Score: 0.037
-
CommunityRx, a social care assistance intervention for family and friend caregivers delivered at the point of care: two concurrent blinded randomized controlled trials. Trials. 2023 Oct 21; 24(1):681.
Score: 0.027
-
The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence. J Cardiovasc Transl Res. 2012 Aug; 5(4):380-7.
Score: 0.024
-
Cost and healthcare utilization analysis of culturally sensitive, shared medical appointment model for Latino children with type 1 diabetes. Pediatr Diabetes. 2021 08; 22(5):816-822.
Score: 0.022
-
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther. 2011 Mar; 13(3):351-8.
Score: 0.022
-
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care. 2011 Mar; 34(3):586-90.
Score: 0.022
-
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
Score: 0.020
-
Provider and Staff Morale, Job Satisfaction, and Burnout over a 4-Year Medical Home Intervention. J Gen Intern Med. 2019 06; 34(6):952-959.
Score: 0.019
-
Health utilities for children and adults with type 1 diabetes. Med Care. 2011 Oct; 49(10):924-31.
Score: 0.012
-
Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene. 2011 Sep 15; 30(37):3907-17.
Score: 0.011
-
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009 Nov; 32(11):1947-53.
Score: 0.010
-
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009 Aug; 32(8):1378-83.
Score: 0.010
-
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 02; 359(14):1464-76.
Score: 0.009